Authors: WERMUTH L SORENSEN PS TIMM S CHRISTENSEN B UTZON NP BOAS J DUPONT E HANSEN E MAGNUSSEN I MIKKELSEN B WORMPETERSEN J LAURITZEN L BAYER L BECH P

Citation: L. Wermuth et al., DEPRESSION IN IDIOPATHIC PARKINSONS-DISEASE TREATED WITH CITALOPRAM -A PLACEBO-CONTROLLED TRIAL, Nordic journal of psychiatry, 52(2), 1998, pp. 163-169

Authors: RINNE UK LARSEN JP SIDEN A WORMPETERSEN J

Citation: Uk. Rinne et al., ENTACAPONE ENHANCES THE RESPONSE TO LEVODOPA IN PARKINSONIAN-PATIENTSWITH MOTOR FLUCTUATIONS, Neurology, 51(5), 1998, pp. 1309-1314

Authors: LARSEN JP BOAS J AASLY J BOESEN F BOISEN E BORGMANN R DUPONT E ERDAL JE GILHUS NE HEINONEN E HUNSTAD N KILKKU O MAI J MELLGREN SI MIKKELSEN B NESSLER E SELSETH B VILMING S WERMUTH L WORMPETERSEN J OKSETER K

Citation: Jp. Larsen et al., THE EFFECTS OF EARLY SELEGILINE THERAPY ON LONG-TERM LEVODOPA TREATMENT AND PARKINSONIAN DISABILITY - AN INTERIM ANALYSIS OF A NORWEGIAN-DANISH 5-YEAR STUDY, Movement disorders, 12(2), 1997, pp. 175-182

Authors: BOAS J WORMPETERSEN J DUPONT E MIKKELSEN B WERMUTH L

Citation: J. Boas et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE IN AN OPEN-LABEL, CROSSOVER STUDY, European journal of neurology, 3(1), 1996, pp. 44-49

Authors: DUPONT E BOAS J MIKKELSEN B WERMUTH L WORMPETERSEN J

Citation: E. Dupont et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE, European journal of neurology, 3, 1996, pp. 9-12

Authors: DUPONT E ANDERSEN A BOAS J BOISEN E BORGMANN R HELGETVEIT AC KJAER MO KRISTENSEN TN MIKKELSEN B PAKKENBERG H PRESTHUS J STIEN R WORMPETERSEN J BUCH D

Citation: E. Dupont et al., SUSTAINED-RELEASE MADOPAR HBS(R) COMPARED WITH STANDARD MADOPAR(R) INTHE LONG-TERM TREATMENT OF DE-NOVO PARKINSONIAN-PATIENTS, Acta neurologica Scandinavica, 93(1), 1996, pp. 14-20